You're on the Right Track with Sandostatin LAR® Depot
More than a decade of clinical excellence with octreotide — the active ingredient in Sandostatin LAR® Depot. A time tested and trusted safety profile. The most prescribed drug in its class. These are some of the reasons you can feel confident in Sandostatin LAR® Depot.
What Is Sandostatin LAR® Depot?
Sandostatin LAR® Depot (octreotide acetate for injectable suspension) is a once-a-month somatostatin analogue administered by your health care professional. Sandostatin LAR® Depot is a different preparation of immediate release Sandostatin® (octreotide acetate) Injection — a drug with over 10 years of clinical experience. Because you receive it only once a month, Sandostatin LAR® Depot may have a significant impact on simplifying the management of your care.
Sandostatin LAR® Depot is indicated for long-term maintenance therapy in patients with acromegaly and in the treatment of symptoms related to carcinoid syndrome and VIPomas.
Read the full prescribing information (PDF 332KB) for Sandostatin LAR® Depot, and see important information about Sandostatin LAR® Depot.
